Global Drug Abuse Testing
Market Report
2024
Drug Abuse Testing Market Report 2024 (Global Edition)
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Drug Abuse Testing Market Report 2024.
Global Drug Abuse Testing Market Report 2024 Market Size Split by Component (Consumables, Instruments, Rapid Testing Devices, Services), by Sample Type (Urine samples, Oral Fluid Samples, Hair Sample...
According to Cognitive Market Research, The Drug Abuse Testing Market will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.
North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX % from 2024 to 2031.
The Europe region is the fastest growing market with a CAGR of XX% from 2024 to 2031 and it is projected that it will grow at a CAGR of XX% in the future.
Asia Pacific accounted for a market share of over XX% of the global revenue with a market size of USD XX million.
Latin America had a market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The Drug Abuse Testing Market held the highest market revenue share in 2024.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Market Size | 121212 |
| Country Market Size | 121212 |
| North Americ Market Size | 121212 |
| Europe Market Size | 121212 |
| Asia Pacific Market Size | 121212 |
| South America Market Size | 121212 |
| Middle East and Africa Market Size | 121212 |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
| Market Split by Component |
|
| Market Split by Sample Type |
|
| Market Split by Drug Type |
|
| Market Split by Technique |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Drug Abuse Testing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Drug Abuse Testing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Drug Abuse Testing Market Report Description
Introduction of The Drug Abuse Testing Market
A drug-of-abuse test essentially examines biological samples such as breath, urine, hair, and oral fluids to find out whether the patient has abused drugs or any of its metabolites. To ascertain if a person is or was under the influence of drugs at any particular time, drug abuse tests are utilized.
The growth in the forecast period can be attributed to increased use of alcohol and other illicit drugs, a rise in drug-related crimes, growing awareness and education, road accidents, corporate wellness initiatives, and improvements in testing techniques are all contributing factors to the growth in the forecast period. The forecast period will witness several notable trends, such as the growing demand for cannabis testing, the use of portable and handheld testing devices, the adoption of laboratory information management systems (LIMS), the emphasis on synthetic drug testing, and the integration of artificial intelligence (AI) for result interpretation.
Market Dynamics of The Drug Abuse Testing Market
Key Drivers for The Drug Abuse Testing Market
- Increase in road accidents due to alcohol consumption growing the market for drug abuse testing.
The number of people killed and injured in traffic accidents, whether they occur right away or 30 days later, are the metrics used to assess these incidents. Alcohol and other substances impair reflexes, judgment, decision-making, impulse control, and motor function, which increases the risk of traffic accidents and frequently results in fatalities. The World Health Organization (WHO) estimates that between 20 and 50 million people get non-fatal injuries and 1.3 million people die in traffic accidents each year. Rising road accidents through alcohol consumption have increased drug abuse testing due to this the market is growing.
For instance, according to the 2021 National Survey on Drug Use and Health (NSDUH), in 2021, around 57.8% of people aged 12 years and more used tobacco, alcohol, and illicit drugs. Further, 47.5% of them were alcohol consumers, 19.5% took tobacco, and 14.3% used illicit drugs. Additionally, it is well-known that men are more likely to consume drugs and alcohol than women.
Source:(https://www.samhsa.gov/data/sites/default/files/2022-12/2021NSDUHFFRHighlights092722.pdf)
For instance, in October 2023, In India, Kerala police launched a rapid drug screening system that uses saliva samples and gives results in five minutes. The hand-held device, the SoToxa Mobile Test System, has been deployed on a trial basis in Thiruvananthapuram city, and depending on its reliability and accuracy, the system will be expanded to other parts of the state as well. Over the past two days, the police have booked 11 people for narcotic abuse through a roadside drive using this device that helps in identifying those who took drugs even two days before
Source:(https://www.onmanorama.com/news/kerala/2023/10/08/police-launch-new-device-detect-drug-use-in-5-minutes.html)
After alcohol, marijuana is most frequently detected in the blood of drivers who have been in accidents. The mind-altering component of marijuana, delta-9-tetrahydrocannabinol (THC), which is found in blood, sometimes takes center stage during an inquiry. Furthermore, compared to when the substances are taken separately, marijuana may increase the risk of car accidents when combined with cocaine, alcohol, or benzodiazepines.
Therefore, in the future, the frequency of drug misuse testing will be determined by the rising incidence of such adverse occurrences.
- The increasing prevalence of drug abuse treatment drives growth in the drug abuse testing market.
The increasing prevalence of drug abuse has led to a rising demand for drug abuse treatment, consequently driving growth in the drug abuse testing market. With a greater focus on identifying and addressing substance abuse issues, there's a corresponding need for accurate and efficient testing methods to monitor and manage treatment progress effectively. The growing consumption of illicit drugs by individuals needs to have drug abuse treatment which in turn increases the prevalence of drug abuse treatment hence it has led to drive the market growth of drug abuse testing.
For instance, in June 2021, according to the United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug abuse disorders. Therefore, the increasing prevalence of drug abuse treatment is driving the Drug Abuse Testing (DOA) testing market.
Source:(https://www.unodc.org/unodc/press/releases/2021/June/unodc-world-drug-report-2021_-pandemic-effects-ramp-up-drug-risks--as-youth-underestimate-cannabis-dangers.html)
Hence, the increasing prevalence of drug abuse necessitates effective treatment, driving growth in drug abuse testing. With a focus on identifying and managing substance abuse issues, demand for accurate testing methods rises to monitor treatment progress.
Restraint Factor for The Drug Abuse Testing Market
- Prohibition of drug abuse testing in the workplace may hamper the market growth of drug abuse testing.
Prohibitions on drug abuse testing in the workplace pose a potential hindrance to the growth of the drug abuse testing market. While workplace testing is a significant segment of drug testing services, restrictions or prohibitions may limit the adoption of these services, thereby impacting market expansion. Such regulations may stem from concerns over privacy, discrimination, or legal implications, creating barriers to the widespread implementation of drug testing programs in employment settings.
For instance, Connecticut law generally prohibits private-sector employers from requiring employees to undergo random drug tests unless the state labor commissioner has designated their occupations as high-risk or safety-sensitive. Additionally, some countries such as Canada, Colombia, Argentina, Chile, and South Africa, regard workplace drug and alcohol testing to be a violation of employee privacy. Such bans in certain nations may restrict the adoption of drug and alcohol screening and, hence may act as a restraint on the market value.
Source:(https://www.cga.ct.gov/PS95/rpt/olr/htm/95-R-1335.htm)
Prohibitions on drug abuse testing in the workplace pose a challenge to the growth of the drug abuse testing market. Workplace testing is a major segment for these services, but restrictions can limit adoption, hindering market expansion. Concerns over privacy, discrimination, and legal issues drive such regulations, creating barriers to the widespread implementation of drug testing programs in employment settings.
How did COVID-19 impact The Drug Abuse Testing Market
The COVID-19 epidemic had a major effect on the drug abuse testing market. An increase in employees working from home and widespread worries about COVID-19 protections are blamed for the decline in the number of persons getting tested. The COVID-19 pandemic has had a notable impact on the drug abuse market, primarily due to a decline in testing volumes resulting from various factors. With more employees working remotely, there's been a reduction in the number of individuals subject to workplace drug testing, contributing to decreased demand for testing services. Additionally, heightened concerns about safety measures and the transmission of COVID-19 have led to a reluctance among individuals to visit testing facilities, further dampening market activity.
For instance, as per research data published by the National Institute of Health, in 2021, Testing for prescription and illicit drugs declined rapidly during the pandemic, with weekly test volumes falling by approximately 70% from the baseline period to the trough (the week beginning March 29) before rising in subsequent weeks. Among individuals tested, positivity increased by 35% for non-prescribed fentanyl and 44% for heroin during the pandemic. Thus, decreased drug abuse testing had a significant impact on the market during the pandemic.
Source:(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875135/)
Opportunities for The Drug Abuse Testing Market
- The growing focus on the development of innovative drug abuse testing services represents a significant opportunity to drive the growth of the drug abuse testing market.
The growing emphasis on developing innovative drug abuse testing services presents a substantial opportunity for expanding the drug abuse testing market. As technology advances and regulatory standards evolve, there's a heightened demand for more sophisticated testing solutions that offer enhanced sensitivity, specificity, and convenience. This demand drives investment in research and development, fostering the creation of novel testing methodologies and services to meet evolving needs.
Millions of individuals worldwide are affected by the global epidemic of drug usage and addiction. To satisfy this rising demand, several significant companies in the drug misuse testing space are launching cutting-edge and effective testing programs.
For instance, in December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services launched urine drugs of abuse testing services. These are relatively easy to do, have quick effects, and are reasonably priced. The lab offers urine drug testing services and is accredited by SAMHSA, guaranteeing the best caliber and precision in test findings. The organization offers over 6,000 clients worldwide laboratory-based sophisticated testing solutions. Both screening and confirmatory testing are used in urine drug abuse testing services to guarantee the precision and dependability of the results.
Source:(https://www.omegalaboratories.com/about-omega/news)
For instance, in May 2020, Psychemedics Corporation, a U.S.-based drug testing service provider, introduced its latest Vaping Panel to help detect the use of CBD, nicotine, and marijuana. This test was developed to help schools and companies identify the intake of these drugs by all modes, including smoking or using e-cigarettes. Thus, the market is expected to show lucrative opportunities wherein key emerging players can gain a competitive edge by introducing innovative drug testing services.
Source:(https://www.psychemedics.com/blog/2020/05/psychemedics-announces-a-vaping-panel-to-detect-and-deter-the-use-of-marijuana-cbd-and-nicotine/)
Therefore, the growing focus on innovative drug abuse testing services is a significant opportunity for market expansion. Advances in technology and evolving standards drive demand for sophisticated testing solutions, prompting investment in research and development to meet the needs of those affected by drug addiction.
We have various report editions of Drug Abuse Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape: The Drug Abuse Testing Market
The major competitors in the market are competing with one another due to the growing demand for drug misuse testing services and their adoption of various industry trends. The main players have developed a strong product portfolio by embracing a variety of items. To capture significant market shares, they have introduced new drugs and exploited drug abuse test market technologies. The major companies and government agencies have prepared several tactics that might encourage the market for drug misuse testing equipment to be adopted. Pharmaceutical corporations have been spending substantial sums of money to find new medications to treat a range of illnesses.
For instance, in February 2021, Thermo Fisher Scientific Inc., a US-based company that provides scientific research services partnered with Mindray Medical International Limited. This partnership seeks to offer clinical laboratories, hospitals, and the criminal justice system dependable and affordable drug misuse screening tools. Through this partnership, Thermo Fisher Scientific meets the demands of testing facilities looking to enhance or broaden their testing capabilities as well as testing facilities trying to combine and centralize their testing. Mindray Medical International Limited is a China-based medical technology company that designs and manufactures medical equipment and devices.
Source:(https://corporate.thermofisher.com/content/tfcorpsite/us/en/index/newsroom/press-releases/2021/Feb/09-Thermo-Fisher-Scientific-Partners-with-Mindray-on-Clinical-Chemistry-Analyzers-for-use-with-Drugs-of-Abuse-Immunoassays.html)
Top Companies Market Share in Drug Abuse Testing Industry: (In no particular order of Rank)
- Abbott Laboratories
- Quest Diagnostics Incorporated
- Express Diagnostics
- Thermo Fisher Scientific Inc.
- Siemens AG
- Pfizer
- Dragerwerk AG & Co. KGAA
- OraSure
- Hoffmann-La Roche AG
- Premier Biotech
- Alfa Scientific Designs
- MPD
- SureHire
- Lifeloc
- Omega Laboratories
- CannAmm
- Shimadzu
- Psychemedics
- Laboratory Corporation of America Holdings (LabCorp)
- Randox Laboratories
- Sonic Healthcare
- Bio-Rad Laboratories
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of The Drug Abuse Testing Market
Which Region Will Dominate the Market in 2024?
According to Cognitive Research, the North American region dominated the market and accounted for the highest revenue of XX% in 2024 and it is projected that it will grow at a CAGR of XX% in the future. In North America, the U.S. holds the majority of market share, of 90%, attributed to the growing number of people abusing illegal substances and the resulting health issues. The other reasons driving the market's expansion are the growing prevalence of workplace drug monitoring programs and the rise in drug trafficking operations.
For instance, in 2021, findings by the National Center for Drug Abuse Statistics (NCDAS) show about 19.4 percent of Americans have used illegal substances at least once. Out of the 280 million aged 12 and older, 31.9 million are drug users, with 11.7 percent on illegal substances and 19.4 percent either having consumed illicit drugs or misused prescription drugs in 2020. The rising consumption of drugs to deal with stress, mental health issues, and high workload are boosting Drug Abuse Testing activities.
Source:(https://www.fmprc.gov.cn/eng/wjdt_665385/2649_665393/202302/t20230209_11022554.html#:~:text=In%202021%2C%20findings%20by%20NCDAS,misused%20prescription%20drugs%20in%202020.)
In the U.S., approximately 37 million people were drug consumers in 2020, and the rate of consumption is increasing by over 13% every year. Males are consuming more drugs compared to females, and since 2000, almost 1 million drug overdose deaths have occurred in the country. Hence, with the increasing number of fatalities, governments, corporations, and even concerned friends and family members are augmenting their DOA testing efforts.
Due to this, the United States government has put the National Drug Control Strategy into effect. It expands on the major steps made in the first year of the Biden Administration to lower the number of overdose deaths, enhance national efforts to inform the public about the dangers of intoxicating substances, and address the supply and demand for them.
Which Region Is Expanding at The Fastest CAGR?
Europe is projected to grow at a faster rate during the forecast period between 2024 and 2031. Europe accounted for the second-largest market share for drug abuse testing services. This is explained by the rising rates of drug usage and substance use disorders in the UK, Germany, France, Italy, and Spain, among other nations. Furthermore, a strong demand for drug abuse testing services is predicted as a result of numerous regulatory authorities' attempts to expand drug abuse testing. Furthermore, it is expected that the major companies would benefit greatly from the growing number of government attempts to expand drug testing. However, many European countries have prohibited workplace drug testing or random screening, while Others permit it in sectors that are vital to safety, like construction, transportation, and energy. Certain nations have ambiguous laws about occupational drug testing, which might impede the market and reduce demand for drug abuse testing services.
For instance, in November 2020 according to the data published by the Organisation for Economic Co-operation and Development (OECD) published in 2020, almost one-third of adults in the European Union aged 15-64, or around 97 million people have used illicit drugs at some point in their lives, with the experience of drug use being more frequently reported by men than women.
Source:(https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe-2020_fc8a3fcf-en)
Therefore, leading players in the drug abuse testing business are diversifying their product lines and updating software to include new substances for drug abuse testing to maintain their market share and competitiveness.
The current report Scope analyzes Drug Abuse Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Drug Abuse Testing Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Drug Abuse Testing Market Analysis
Global Drug Abuse Testing Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Drug Abuse Testing Industry growth. Drug Abuse Testing market has been segmented with the help of its Component , Sample Type Drug Type , and others. Drug Abuse Testing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Segment Performance in The Drug Abuse Testing Market
Component Segment Analysis
The services segment accounted for the largest revenue share. As regulations governing drug testing become increasingly stringent, and the need for accurate and reliable results escalates, many organizations find it more efficient and cost-effective to rely on specialized testing services. These services offer expertise in handling complex testing procedures, ensuring compliance with regulatory standards, and delivering timely and accurate results. The segmental expansion has been driven by a rise in strategic activities being carried out by different organizations, such as partnerships, acquisitions, and collaborations to help government agencies and public safety.
For instance, in August 2020, Averhealth acquired drug testing services from the Treatment Assessment Screening Center (TASC). Averhealth is expected to provide enhanced substance use monitoring services for TASC's clients.
Source:(https://www.prnewswire.com/news-releases/averhealth-expands-its-national-footprint-with-the-acquisition-of-treatment-assessment-screening-center-tasc-drug-testing-services-301119943.html)
Drug Abuse Testing Market Share (%) by Component in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Drug Abuse Testing Industry. Request a Free Sample PDF!
Sample Type Segment Analysis
The urine samples segment dominated the market and accounted for the largest revenue share. Urine samples are the most often utilized sample type to identify the presence of illegal drugs, which may account for this significant rise. urine collection is non-invasive and relatively straightforward, making it more acceptable to individuals undergoing testing. Additionally, urine samples offer a wider detection window compared to other sample types, allowing for the identification of drug use over a longer period. This extended detection window is particularly valuable for routine screening and monitoring purposes, such as employment drug testing programs and rehabilitation initiatives. Overall, the ease of collection, non-invasiveness, and extended detection capabilities of urine samples have propelled them to the forefront of Drug Abuse Testing.
Drug Abuse Testing Market Share (%) by Sample Type in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Drug Abuse Testing Drug Type Segment Analysis
Drug Type Segment Analysis
The cannabis/marijuana segment dominated the drug testing market and accounted for the largest revenue share. There is a strong need for marijuana testing kits and devices as cannabis/ marijuana, is the most widely used illegal substance in the markets. The legalization of cannabis for medical and recreational use in various jurisdictions has led to a significant increase in its consumption rates. Consequently, there is a growing need for drug testing solutions specifically tailored to detect cannabis use accurately. This demand is further fueled by regulatory requirements for workplace drug testing, legal compliance testing, and law enforcement purposes. As a result, testing methods and products designed specifically for cannabis/marijuana detection have witnessed a surge in demand, driving the dominance of this segment in the drug abuse testing market.
For instance, according to the National Survey on Drug Use and Health (NSDUH), marijuana was the most widely used illicit substance in the U.S., with 43.5 million users. The opioids segment occupied the second largest revenue in 2020 due to the increased opioid crises in significant markets, including North America, and novel testing methods.
Source:(https://www.fmprc.gov.cn/eng/wjdt_665385/2649_665393/202302/t20230209_11022554.html#:~:text=In%202021%2C%20findings%20by%20NCDAS,misused%20prescription%20drugs%20in%202020.)
- Alcohol
- Cannabis/Marijuana
- Cocaine
- Opioids
- Amphetamine & Methamphetamine
- LSD
- Other Drug Types
Drug Abuse Testing Technique Segment Analysis
Technique Segment Analysis
The immunoassay segment holds the largest market share. Immunoassays are frequently used in clinical settings to quickly identify medications in urine. The enzyme multiplied immunoassay method (EMIT), cloned enzyme donor immunoassay (CEDIA), chemiluminescent immunoassays (CLIA), kinetic interaction of microparticle in solution (KIMS), and other formats are often utilized for drug misuse testing. Advanced drug testing panels and immunoassays for drug testing applications have been launched and improved by many major companies worldwide, which is anticipated to have a favorable influence on the segment's growth throughout the projected period.
For instance, in December 2023, Quest Diagnostics, one of the significant providers of diagnostic information services, launched a new confirmatory testing service for novel psychoactive substances (NPS). The new panel, which tests for 88 compounds, covers a broad array of drug classes, such as designer opioids, designer benzodiazepines, designer stimulants, fentanyl analogs, synthetic cannabinoids, and other illicit additives.
Source:(https://newsroom.questdiagnostics.com/2023-12-19-Quest-Diagnostics-Launches-New-88-Compound-Novel-Psychoactive-Substance-Test-Panel)
For instance, in October 2023, ProciseDx Inc. received de novo FDA clearance for the therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, called Procise ADL and Procise IFX, are used to quantify adalimumab (ADL) and infliximab (IFX) in patients suffering from inflammatory bowel diseases (IBD) who are taking these drugs. ProciseDx planned to commercialize these first FDA-cleared infliximab and adalimumab drug monitoring tests in Q4 2023.
Source:(https://www.prnewswire.com/news-releases/procisedx-announces-the-first-fda-cleared-therapeutic-drug-monitoring-tests-for-biologic-drugs-humira-remicade-and-their-biosimilars-301945126.html)
- Immunoassay
- Chromatography
- Rapid Testing
Drug Abuse Testing End User Segment Analysis
End User Segment Analysis
Drug testing laboratories dominated the market and held the largest revenue share. Their high share might be attributed to their widespread acceptance as a consequence of their precise findings. Drug testing facilities can detect the presence of any illegal substance, something that is not achievable with fast tests. The availability of advanced instruments, such as spectroscopy and HPLC, and skilled staff who can conduct tests with accurate findings are two further benefits of drug testing labs. For this reason, laboratory results are more sensitive and specific than those obtained from quick tests.
- Hospitals
- Drug testing laboratories
- Forensic Laboratories
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
With the help of the above study about the Drug Abuse Testing Market, it can be concluded that the market for Drug Abuse Testing worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Drug Abuse Testing Market
In June 2022- The Punjab Government in India introduced a drug testing initiative to detect drug abuse in prisons. The screening of more than 8,000 inmates in more than 14 prisons revealed that 42 percent of prisoners were drug addicts.
Source:(https://www.indiatoday.in/india/story/punjab-government-launches-drug-screening-drive-in-jails-inmates-test-positive-1979949-2022-07-26)
In December 2022- Omega Laboratories ("Omega"), a prominent provider of laboratory testing solutions, introduced Urine Drugs of Abuse testing services in its state-of-the-art Ontario, Canada laboratory. In addition to its molecular testing, the laboratory will offer Urine Drug Testing starting on January 3, 2022.
Source:(https://www.omegalaboratories.com/)
In December 2020, Clinical Reference Laboratory acquired Confirm BioSciences, which is one of the leading providers of comprehensive testing tools and solutions, aiding in the expansion of Confirm's access to lab testing services and research and development capabilities, which may help CRL due to Confirm's huge customer base in drug abuse testing.
Source:(https://www.biospace.com/article/releases/confirm-biosciences-acquired-by-clinical-reference-laboratory/)
In April 2020, Cordant Health Solutions started an oral fluid drug testing solution based on telemedicine to assist in offering critical care to individuals recovering from substance use disorder.
Source:(https://cordantsolutions.com/telemedicine-solution-for-drug-testing-during-covid-19-pandemic/)
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Drug Abuse Testing Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Component | Consumables, Instruments, Rapid Testing Devices, Services |
| Sample Type | Urine samples, Oral Fluid Samples, Hair Sample, Other Samples |
| Drug Type | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
| Technique | Immunoassay, Chromatography, Rapid Testing |
| End User | Hospitals, Drug testing laboratories, Forensic Laboratories, Others |
| List of Competitors | Abbott Laboratories, Quest Diagnostics Incorporated, Express Diagnostics, Thermo Fisher Scientific Inc., Siemens AG, Pfizer, Dragerwerk AG & Co. KGAA, OraSure, Hoffmann-La Roche AG, Premier Biotech, Alfa Scientific Designs, MPD, SureHire, Lifeloc, Omega Laboratories, CannAmm, Shimadzu, Psychemedics, Laboratory Corporation of America Holdings (LabCorp), Randox Laboratories, Sonic Healthcare, Bio-Rad Laboratories |
This chapter will help you gain GLOBAL Market Analysis of Drug Abuse Testing. Further deep in this chapter, you will be able to review Global Drug Abuse Testing Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Drug Abuse Testing Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Drug Abuse Testing Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Drug Abuse Testing Revenue Market Size By Region
-
-
1.3 Global Drug Abuse Testing Market Size By Component 2019 -2031
-
1.3.1 Consumables Market Size
-
1.3.2 Instruments Market Size
-
1.3.3 Rapid Testing Devices Market Size
-
1.3.4 Services Market Size
-
-
1.4 Global Drug Abuse Testing Market Size By Sample Type 2019 -2031
-
1.4.1 Urine samples Market Size
-
1.4.2 Oral Fluid Samples Market Size
-
1.4.3 Hair Sample Market Size
-
1.4.4 Other Samples Market Size
-
-
1.5 Global Drug Abuse Testing Market Size By Drug Type 2019 -2031
-
1.5.1 Alcohol Market Size
-
1.5.2 Cannabis/Marijuana Market Size
-
1.5.3 Cocaine Market Size
-
1.5.4 Opioids Market Size
-
1.5.5 Amphetamine & Methamphetamine Market Size
-
1.5.6 LSD Market Size
-
1.5.7 Other Drug Types Market Size
-
-
1.6 Global Drug Abuse Testing Market Size By Technique for 2019 -2031
-
1.6.1 Immunoassay Market Size
-
1.6.2 Chromatography Market Size
-
1.6.3 Rapid Testing Market Size
-
-
1.7 Global Drug Abuse Testing Market Size By End User for 2019 -2031
-
1.7.1 Hospitals Market Size
-
1.7.2 Drug testing laboratories Market Size
-
1.7.3 Forensic Laboratories Market Size
-
1.7.4 Others Market Size
-
-
1.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.9 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.9.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.9.2 Global Market Revenue Split By Component
-
1.9.3 Global Market Revenue Split By Sample Type
-
1.9.4 Global Market Revenue Split By Drug Type
-
1.9.5 Global Market Revenue Split By Technique
-
1.9.6 Global Market Revenue Split By End User
-
1.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Drug Abuse Testing Market Size 2019 - 2031
-
2.1.1 North America Drug Abuse Testing Market Size By Country 2019 - 2031
-
2.1.2 North America Drug Abuse Testing Market Size by Component 2019 -2031
-
2.1.2.1 North America Consumables Market Size
-
2.1.2.2 North America Instruments Market Size
-
2.1.2.3 North America Rapid Testing Devices Market Size
-
2.1.2.4 North America Services Market Size
-
-
2.1.3 North America Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
2.1.3.1 North America Urine samples Market Size
-
2.1.3.2 North America Oral Fluid Samples Market Size
-
2.1.3.3 North America Hair Sample Market Size
-
2.1.3.4 North America Other Samples Market Size
-
-
2.1.4 North America Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
2.1.4.1 North America Alcohol Market Size
-
2.1.4.2 North America Cannabis/Marijuana Market Size
-
2.1.4.3 North America Cocaine Market Size
-
2.1.4.4 North America Opioids Market Size
-
2.1.4.5 North America Amphetamine & Methamphetamine Market Size
-
2.1.4.6 North America LSD Market Size
-
2.1.4.7 North America Other Drug Types Market Size
-
-
2.1.5 North America Drug Abuse Testing Market Size by Technique 2019 -2031
-
2.1.5.1 North America Immunoassay Market Size
-
2.1.5.2 North America Chromatography Market Size
-
2.1.5.3 North America Rapid Testing Market Size
-
-
2.1.6 North America Drug Abuse Testing Market Size by End User 2019 -2031
-
2.1.6.1 North America Hospitals Market Size
-
2.1.6.2 North America Drug testing laboratories Market Size
-
2.1.6.3 North America Forensic Laboratories Market Size
-
2.1.6.4 North America Others Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Drug Abuse Testing Market Size 2019 - 2031
-
3.1.1 Europe Drug Abuse Testing Market Size By Country 2019 - 2031
-
3.1.2 Europe Drug Abuse Testing Market Size by Component 2019 -2031
-
3.1.2.1 Europe Consumables Market Size
-
3.1.2.2 Europe Instruments Market Size
-
3.1.2.3 Europe Rapid Testing Devices Market Size
-
3.1.2.4 Europe Services Market Size
-
-
3.1.3 Europe Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
3.1.3.1 Europe Urine samples Market Size
-
3.1.3.2 Europe Oral Fluid Samples Market Size
-
3.1.3.3 Europe Hair Sample Market Size
-
3.1.3.4 Europe Other Samples Market Size
-
-
3.1.4 Europe Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
3.1.4.1 Europe Alcohol Market Size
-
3.1.4.2 Europe Cannabis/Marijuana Market Size
-
3.1.4.3 Europe Cocaine Market Size
-
3.1.4.4 Europe Opioids Market Size
-
3.1.4.5 Europe Amphetamine & Methamphetamine Market Size
-
3.1.4.6 Europe LSD Market Size
-
3.1.4.7 Europe Other Drug Types Market Size
-
-
3.1.5 Europe Drug Abuse Testing Market Size by Technique 2019 -2031
-
3.1.5.1 Europe Immunoassay Market Size
-
3.1.5.2 Europe Chromatography Market Size
-
3.1.5.3 Europe Rapid Testing Market Size
-
-
3.1.6 Europe Drug Abuse Testing Market Size by End User 2019 -2031
-
3.1.6.1 Europe Hospitals Market Size
-
3.1.6.2 Europe Drug testing laboratories Market Size
-
3.1.6.3 Europe Forensic Laboratories Market Size
-
3.1.6.4 Europe Others Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Drug Abuse Testing Market Size 2019 - 2031
-
4.1.1 Asia Pacific Drug Abuse Testing Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Drug Abuse Testing Market Size by Component 2019 -2031
-
4.1.2.1 Asia Pacific Consumables Market Size
-
4.1.2.2 Asia Pacific Instruments Market Size
-
4.1.2.3 Asia Pacific Rapid Testing Devices Market Size
-
4.1.2.4 Asia Pacific Services Market Size
-
-
4.1.3 Asia Pacific Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
4.1.3.1 Asia Pacific Urine samples Market Size
-
4.1.3.2 Asia Pacific Oral Fluid Samples Market Size
-
4.1.3.3 Asia Pacific Hair Sample Market Size
-
4.1.3.4 Asia Pacific Other Samples Market Size
-
-
4.1.4 Asia Pacific Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
4.1.4.1 Asia Pacific Alcohol Market Size
-
4.1.4.2 Asia Pacific Cannabis/Marijuana Market Size
-
4.1.4.3 Asia Pacific Cocaine Market Size
-
4.1.4.4 Asia Pacific Opioids Market Size
-
4.1.4.5 Asia Pacific Amphetamine & Methamphetamine Market Size
-
4.1.4.6 Asia Pacific LSD Market Size
-
4.1.4.7 Asia Pacific Other Drug Types Market Size
-
-
4.1.5 Asia Pacific Drug Abuse Testing Market Size by Technique 2019 -2031
-
4.1.5.1 Asia Pacific Immunoassay Market Size
-
4.1.5.2 Asia Pacific Chromatography Market Size
-
4.1.5.3 Asia Pacific Rapid Testing Market Size
-
-
4.1.6 Asia Pacific Drug Abuse Testing Market Size by End User 2019 -2031
-
4.1.6.1 Asia Pacific Hospitals Market Size
-
4.1.6.2 Asia Pacific Drug testing laboratories Market Size
-
4.1.6.3 Asia Pacific Forensic Laboratories Market Size
-
4.1.6.4 Asia Pacific Others Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Drug Abuse Testing Market Size 2019 - 2031
-
5.1.1 South America Drug Abuse Testing Market Size By Country 2019 - 2031
-
5.1.2 South America Drug Abuse Testing Market Size by Component 2019 -2031
-
5.1.2.1 South America Consumables Market Size
-
5.1.2.2 South America Instruments Market Size
-
5.1.2.3 South America Rapid Testing Devices Market Size
-
5.1.2.4 South America Services Market Size
-
-
5.1.3 South America Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
5.1.3.1 South America Urine samples Market Size
-
5.1.3.2 South America Oral Fluid Samples Market Size
-
5.1.3.3 South America Hair Sample Market Size
-
5.1.3.4 South America Other Samples Market Size
-
-
5.1.4 South America Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
5.1.4.1 South America Alcohol Market Size
-
5.1.4.2 South America Cannabis/Marijuana Market Size
-
5.1.4.3 South America Cocaine Market Size
-
5.1.4.4 South America Opioids Market Size
-
5.1.4.5 South America Amphetamine & Methamphetamine Market Size
-
5.1.4.6 South America LSD Market Size
-
5.1.4.7 South America Other Drug Types Market Size
-
-
5.1.5 South America Drug Abuse Testing Market Size by Technique 2019 -2031
-
5.1.5.1 South America Immunoassay Market Size
-
5.1.5.2 South America Chromatography Market Size
-
5.1.5.3 South America Rapid Testing Market Size
-
-
5.1.6 South America Drug Abuse Testing Market Size by End User 2019 -2031
-
5.1.6.1 South America Hospitals Market Size
-
5.1.6.2 South America Drug testing laboratories Market Size
-
5.1.6.3 South America Forensic Laboratories Market Size
-
5.1.6.4 South America Others Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Drug Abuse Testing Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Drug Abuse Testing Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Drug Abuse Testing Market Size by Component 2019 -2031
-
6.1.2.1 Middle East and Africa Consumables Market Size
-
6.1.2.2 Middle East and Africa Instruments Market Size
-
6.1.2.3 Middle East and Africa Rapid Testing Devices Market Size
-
6.1.2.4 Middle East and Africa Services Market Size
-
-
6.1.3 Middle East and Africa Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
6.1.3.1 Middle East and Africa Urine samples Market Size
-
6.1.3.2 Middle East and Africa Oral Fluid Samples Market Size
-
6.1.3.3 Middle East and Africa Hair Sample Market Size
-
6.1.3.4 Middle East and Africa Other Samples Market Size
-
-
6.1.4 Middle East and Africa Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
6.1.4.1 Middle East and Africa Alcohol Market Size
-
6.1.4.2 Middle East and Africa Cannabis/Marijuana Market Size
-
6.1.4.3 Middle East and Africa Cocaine Market Size
-
6.1.4.4 Middle East and Africa Opioids Market Size
-
6.1.4.5 Middle East and Africa Amphetamine & Methamphetamine Market Size
-
6.1.4.6 Middle East and Africa LSD Market Size
-
6.1.4.7 Middle East and Africa Other Drug Types Market Size
-
-
6.1.5 Middle East and Africa Drug Abuse Testing Market Size by Technique 2019 -2031
-
6.1.5.1 Middle East and Africa Immunoassay Market Size
-
6.1.5.2 Middle East and Africa Chromatography Market Size
-
6.1.5.3 Middle East and Africa Rapid Testing Market Size
-
-
6.1.6 Middle East and Africa Drug Abuse Testing Market Size by End User 2019 -2031
-
6.1.6.1 Middle East and Africa Hospitals Market Size
-
6.1.6.2 Middle East and Africa Drug testing laboratories Market Size
-
6.1.6.3 Middle East and Africa Forensic Laboratories Market Size
-
6.1.6.4 Middle East and Africa Others Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Drug Abuse Testing Market Size by Component 2019 -2031
-
7.1.2 Country 1Drug Abuse Testing Market Size by Sample Type 2019 -2031
-
7.1.3 Country 1Drug Abuse Testing Market Size by Drug Type 2019 -2031
-
7.1.4 Country 1Drug Abuse Testing Market Size by Technique 2019 -2031
-
7.1.5 Country 1Drug Abuse Testing Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Drug Abuse Testing Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Quest Diagnostics Incorporated
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Express Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Thermo Fisher Scientific Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Siemens AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Pfizer
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Dragerwerk AG & Co. KGAA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 OraSure
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Hoffmann-La Roche AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Premier Biotech
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Alfa Scientific Designs
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 MPD
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 SureHire
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 Lifeloc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Omega Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 CannAmm
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 Shimadzu
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Psychemedics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 Laboratory Corporation of America Holdings (LabCorp)
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
8.2.20 Randox Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.20.2 Business Overview
-
8.2.20.3 Financials (Subject to data availability)
-
8.2.20.4 Product Types Specification
-
8.2.20.5 Business Strategy
-
8.2.20.6 S.W.O.TAnalysis
-
-
8.2.21 Sonic Healthcare
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.21.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.21.2 Business Overview
-
8.2.21.3 Financials (Subject to data availability)
-
8.2.21.4 Product Types Specification
-
8.2.21.5 Business Strategy
-
8.2.21.6 S.W.O.TAnalysis
-
-
8.2.22 Bio-Rad Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.22.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.22.2 Business Overview
-
8.2.22.3 Financials (Subject to data availability)
-
8.2.22.4 Product Types Specification
-
8.2.22.5 Business Strategy
-
8.2.22.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Component Analysis 2019 -2031, will provide market size split by Component . This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Component Analysis 2019 -2031
-
10.1 Consumables
-
10.1.1 Global Drug Abuse Testing Revenue Market Size and Share by Consumables 2019 -2031
-
-
10.2 Instruments
-
10.2.1 Global Drug Abuse Testing Revenue Market Size and Share by Instruments 2019 -2031
-
-
10.3 Rapid Testing Devices
-
10.3.1 Global Drug Abuse Testing Revenue Market Size and Share by Rapid Testing Devices 2019 -2031
-
-
10.4 Services
-
10.4.1 Global Drug Abuse Testing Revenue Market Size and Share by Services 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Sample Type Analysis 2019 -2031
-
11.1 Urine samples
-
11.1.1 Global Drug Abuse Testing Revenue Market Size and Share by Urine samples 2019 - 2031
-
-
11.2 Oral Fluid Samples
-
11.2.1 Global Drug Abuse Testing Revenue Market Size and Share by Oral Fluid Samples 2019 - 2031
-
-
11.3 Hair Sample
-
11.3.1 Global Drug Abuse Testing Revenue Market Size and Share by Hair Sample 2019 - 2031
-
-
11.4 Other Samples
-
11.4.1 Global Drug Abuse Testing Revenue Market Size and Share by Other Samples 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Drug Type Analysis 2019 -2031
-
12.1 Alcohol
-
12.1.1 Global Drug Abuse Testing Revenue Market Size and Share by Alcohol 2019 -2031
-
-
12.2 Cannabis/Marijuana
-
12.2.1 Global Drug Abuse Testing Revenue Market Size and Share by Cannabis/Marijuana 2019 -2031
-
-
12.3 Cocaine
-
12.3.1 Global Drug Abuse Testing Revenue Market Size and Share by Cocaine 2019 -2031
-
-
12.4 Opioids
-
12.4.1 Global Drug Abuse Testing Revenue Market Size and Share by Opioids 2019 -2031
-
-
12.5 Amphetamine & Methamphetamine
-
12.5.1 Global Drug Abuse Testing Revenue Market Size and Share by Amphetamine & Methamphetamine 2019 -2031
-
-
12.6 LSD
-
12.6.1 Global Drug Abuse Testing Revenue Market Size and Share by LSD 2019 -2031
-
-
12.7 Other Drug Types
-
12.7.1 Global Drug Abuse Testing Revenue Market Size and Share by Other Drug Types 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Technique Analysis 2019 -2031
-
13.1 Immunoassay
-
13.1.1 Global Drug Abuse Testing Revenue Market Size and Share by Immunoassay 2019 -2031
-
-
13.2 Chromatography
-
13.2.1 Global Drug Abuse Testing Revenue Market Size and Share by Chromatography 2019 -2031
-
-
13.3 Rapid Testing
-
13.3.1 Global Drug Abuse Testing Revenue Market Size and Share by Rapid Testing 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End User Analysis 2019 -2031
-
14.1 Hospitals
-
14.1.1 Global Drug Abuse Testing Revenue Market Size and Share by Hospitals 2019 -2031
-
-
14.2 Drug testing laboratories
-
14.2.1 Global Drug Abuse Testing Revenue Market Size and Share by Drug testing laboratories 2019 -2031
-
-
14.3 Forensic Laboratories
-
14.3.1 Global Drug Abuse Testing Revenue Market Size and Share by Forensic Laboratories 2019 -2031
-
-
14.4 Others
-
14.4.1 Global Drug Abuse Testing Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Drug Abuse Testing market
Chapter 15 Research Findings
-
15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
15.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Drug Abuse Testing Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Drug Abuse Testing Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Drug Abuse Testing Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Drug Abuse Testing Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Drug Abuse Testing Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Drug Abuse Testing Market
Key Questions Answered By Drug Abuse Testing Market Report 2024
| Why Consumables have a significant impact on Drug Abuse Testing market? |
| What are the key factors affecting the Consumables and Instruments of Drug Abuse Testing Market? |
| What is the CAGR/Growth Rate of Urine samples during the forecast period? |
| By type, which segment accounted for largest share of the global Drug Abuse Testing Market? |
| Which region is expected to dominate the global Drug Abuse Testing Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
